124
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Bufalin-loaded mPEG-PLGA-PLL-cRGD nanoparticles: preparation, cellular uptake, tissue distribution, and anticancer activity

, , , , , , , , & show all
Pages 3961-3969 | Published online: 27 Jul 2012

References

  • HenleySJKingJBGermanRRSurveillance of screening-detected cancers (colon and rectum, breast, and cervix) – United States, 2004–2006MMWR Surveill Summ201059912521102407
  • SjoOHBergMMerokMAPeritoneal carcinomatosis of colon cancer origin: highest incidence in women and in patients with right-sided tumorsJ Surg Oncol2011104779279721547915
  • LuCXNanKJLeiYAgents from amphibians with anticancer propertiesAnticancer Drugs2008191093193918827558
  • CuiXInagakiYXuHAnti-hepatitis B virus activities of cinobufacini and its active components bufalin and cinobufagin in HepG2.2.15 cellsBiol Pharm Bull201033101728173220930383
  • QiFLiAInagakiYAntitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans CantorInt Immunopharmacol201111334234921185919
  • HanKQHuangGGuWAnti-tumor activities and apoptosis-regulated mechanisms of bufalin on the orthotopic transplantation tumor model of human hepatocellular carcinoma in nude miceWorld J Gastroenterol200713243374337917659679
  • LiHWangPGaoYNa+/K+-ATPase alpha3 mediates sensitivity of hepatocellular carcinoma cells to bufalinOncol Rep201125382583021181095
  • AmanoYChoYMatsunawaMIncreased nuclear expression and transactivation of vitamin D receptor by the cardiotonic steroid bufalin in human myeloid leukemia cellsJ Steroid Biochem Mol Biol20091143–514415119429444
  • ZhuZYuYWangKEffect of Bufalin on proliferation and apoptosis of human non-small cell lung cancer A549 cellZhongguo Fei Ai Za Zhi201013984184520840810
  • LiDQuXHouKPI3 K/Akt is involved in bufalin-induced apoptosis in gastric cancer cellsAnticancer Drugs2009201596419343001
  • YuCHKanSFPuHFApoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cellsCancer Sci200899122467247619037992
  • GongLLLiJXZhangHMProgress on pharmacological action and preparation of venenum bufonisFood and Drug20079105153
  • XuYZFanYZhangYLEffects of bufalin on apoptosis of human colon cancer SW620 cellJ Jiangsu University (Medicine Edition)2007176515517
  • XieCMChanWYYuSBufalin induces autophagy-mediated cell death in human colon cancer cells through reactive oxygen species generation and JNK activationFree Radic Biol Med20115171365137521763418
  • BickRJPoindexterBJSweneyRREffects of Chan Su, a traditional Chinese medicine, on the calcium transients of isolated cardiomyocytes: cardiotoxicity due to more than Na, K-ATPase blockingLife Sci200272669970912467910
  • LiuPFZhuMJLiYGWangHZDuanYRThe research on cytotoxicity and cellular uptake of mPEG-PLGA-PLL nanoparticlesProceedings of 2009 international conference on advanced fibers and polymer materials20091–211901192
  • KostakisCByardRWSudden death associated with intravenous injection of toad extractForensic Sci Int20091881–3e1e519303230
  • DasguptaAEmersonLNeutralization of cardiac toxins oleandrin, oleandrigenin, bufalin, and cinobufotalin by digibind: monitoring the effect by measuring free digitoxin concentrationsLife Sci19986397817889740315
  • ZhuDLuXHardyPANanotemplate-engineered nanoparticles containing gadolinium for magnetic resonance imaging of tumorsInvest Radiol200843212914018197065
  • HuKZhuLLiangHImproved antitumor efficacy and reduced toxicity of liposomes containing bufadienolidesArch Pharm Res20113491487149421975810
  • WengYJinJPanCBioavailability and pharmacokinetics of bufadienolides-loaded lipid microspheres after different administrations to ratsJ Lipid Sci Tech2011113910951105
  • LiFWangYLiuZFormulation and characterization of bufadienolides-loaded nanostructured lipid carriersDrug Dev Ind Pharm201036550851719821716
  • BriggerIDubernetCCouvreurPNanoparticles in cancer therapy and diagnosisAdv Drug Deliv Rev200254563165112204596
  • CegnarMKristlJKosJNanoscale polymer carriers to deliver chemotherapeutic agents to tumoursExpert Opin Biol Ther20055121557156916318420
  • MurphyEAMajetiBKBarnesLANanoparticle-mediated drug delivery to tumor vasculature suppresses metastasisProc Natl Acad Sci U S A2008105279343934818607000
  • RyppaCMann-SteinbergHBiniossekMLIn vitro and in vivo evaluation of a paclitaxel conjugate with the divalent peptide E-[c(RGDfK)2] that targets integrin alpha v beta 3Int J Pharm20093681–2899718992308
  • StupackDGPuenteXSBoutsaboualoySApoptosis of adherent cells by recruitment of caspase-8 to unligated integrinsJ Cell Biol2001155345947011684710
  • BurkhartDJKaletBTColemanMPDoxorubicin-formaldehyde conjugates targeting alphavbeta3 integrinMol Cancer Ther20043121593160415634653
  • ZangeRLiYXKisselTBiocompatibility testing of ABA triblock copolymers consisting of poly(L-lactic-co-glycolic acid) A blocks attached to a central poly(ethylene oxide) B block under in vitro conditions using different L929 mouse fibroblasts cell culture modelsJ Control Release1998561–32492589801448
  • SawhneyASPathakCPHubbellJAInterfacial photopolymerization of poly(ethylene glycol)-based Anderson JM, Shive. Biodegradation and biocompatibility of PLA and PLGA microspheresAdv Drug Delivery Rev1997281524
  • JainRShahNHMalickAWRhodesCTControlled drug delivery by biodegradable poly(ester) devices: Different preparative approachesDrug Dev Res1998248703727
  • HudeczFKutassikovacsSMezoGSzekerkeMBiodegradability of synthetic branched polypeptide with poly(l-lysine) backboneBiol. Chem Hoppe-Seyler19893709101910262575393
  • SawhneyASPathakCPHubbellJAInterfacial photopolymerization of poly(ethylene glycol)-based hydrogels upon alginate-poly(l-lysine) microcapsules for enhanced biocompatibilityBiomaterial1993141310081016
  • AkizawaTKinoKKinugasaEClinical effects of a polyethylene glycol grafted cellulose membrane on thrombogenicity and biocompatibility during hemodialysisASAIO transactions/American Society for Artificial Internal Organs1990363M640M6422252772
  • MaedaHWuJSawaTMatsumuraYHoriKTumor vascular permeability and the EPR effect in macromolecular therapeutics: a reviewJ Control Release2000651–227128410699287
  • LiQWangYFengNFanZSunJNanYNovel polymeric nanoparticles containing tanshinone IIA for the treatment of hepatomaJ Drug Target2008161072573219005937
  • LiuDFengJFDetermination of apparent aqueous solubility and apparent oil-water partition coefficients of three bufadienolides compositionZhongguo Zhong Yao Za Zhi200833111256125818831199
  • PanGLemmouchiYAkalaEOStudies on PEGylated and drug-loaded PAMAM dendrimersJ Bioact Compat Pol2005201113128